Literature DB >> 21192925

Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.

Ki Sa Sung1, Yun-Ah Lee, Eui Tae Kim, Seung-Rock Lee, Jin-Hyun Ahn, Cheol Yong Choi.   

Abstract

Homeodomain-interacting protein kinase 2 (HIPK2) is a key regulator of various transcription factors including p53 and CtBP in the DNA damage signaling pathway. PML-nuclear body (NB) is required for HIPK2-mediated p53 phosphorylation at Ser46 and induction of apoptosis. Although PML-NB targeting of HIPK2 has been shown, much is not clear about the molecular mechanism of HIPK2 recruitment to PML-NBs. Here we show that HIPK2 colocalizes specifically with PML-I and PML-IV. Mutational analysis showed that HIPK2 recruitment to PML-IV-NBs is mediated by the SUMO-interaction motifs (SIMs) of both PML-IV and HIPK2. Wild-type HIPK2 associated with SUMO-conjugated PML-IV at a higher affinity than with un-conjugated PML-IV, while the association of a HIPK2 SIM mutant with SUMO-modified PML-IV was impaired. In colony formation assays, HIPK2 strongly suppressed cell proliferation, but HIPK2 SIM mutants did not. In addition, activation and phosphorylation of p53 at the Ser46 residue were impaired by HIPK2 SIM mutants. These results suggest that SIM-mediated HIPK2 targeting to PML-NBs is crucial for HIPK2-mediated p53 activation and induction of apoptosis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21192925     DOI: 10.1016/j.yexcr.2010.12.016

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

Review 1.  PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Nucleus       Date:  2014       Impact factor: 4.197

2.  p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.

Authors:  Cheol-Hee Yoon; Sang-Yoon Kim; Se Eun Byeon; Yideul Jeong; Jinjoo Lee; Kwang Pyo Kim; Jinseu Park; Yong-Soo Bae
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

Review 3.  Posttranslational modifications regulate HIPK2, a driver of proliferative diseases.

Authors:  Vera V Saul; M Lienhard Schmitz
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

4.  Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.

Authors:  Mohamed Ali Maroui; Sabrina Kheddache-Atmane; Faten El Asmi; Laurent Dianoux; Muriel Aubry; Mounira K Chelbi-Alix
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

5.  Regulation of the tumor suppressor PML by sequential post-translational modifications.

Authors:  M Lienhard Schmitz; Inna Grishina
Journal:  Front Oncol       Date:  2012-12-31       Impact factor: 6.244

6.  Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage.

Authors:  Laureano de la Vega; Juliane Hornung; Elisabeth Kremmer; Maja Milanovic; M Lienhard Schmitz
Journal:  Nucleic Acids Res       Date:  2013-04-24       Impact factor: 16.971

Review 7.  Move or die: the fate of the Tax oncoprotein of HTLV-1.

Authors:  Julie Lodewick; Isabelle Lamsoul; Françoise Bex
Journal:  Viruses       Date:  2011-06-15       Impact factor: 5.048

Review 8.  Role of the promyelocytic leukaemia protein in cell death regulation.

Authors:  P Salomoni; M Dvorkina; D Michod
Journal:  Cell Death Dis       Date:  2012-01-12       Impact factor: 8.469

Review 9.  The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies.

Authors:  Hugues de Thé; Morgane Le Bras; Valérie Lallemand-Breitenbach
Journal:  J Cell Biol       Date:  2012-07-09       Impact factor: 10.539

10.  Promyelocytic leukemia (PML) protein plays important roles in regulating cell adhesion, morphology, proliferation and migration.

Authors:  Mei Kuen Tang; Yong Jia Liang; John Yeuk Hon Chan; Sing Wan Wong; Elve Chen; Yao Yao; Jingyi Gan; Lihai Xiao; Hin Cheung Leung; Hsiang Fu Kung; Hua Wang; Kenneth Ka Ho Lee
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.